After ejecting out of Bristol Myers R&D, Rupert Vessey lands at the top science post at a buzzy Flagship
13 Jul 2023
Executive Change
Five months ago, Rupert Vessey
stepped out
of his influential R&D post at Bristol Myers Squibb in a move clearly pointing to a new, though unannounced, chapter in biotech. And he unveiled his next career step today with the news that he’s joining a buzzy Flagship Pioneering as their chief scientist.
It’s a brand new position.
The move takes him out of a Big Pharma that’s been working, sometimes struggling, to manage a major pipeline — including a host of drugs Vessey arranged to in-license for big bucks — and puts him squarely at one of the largest venture groups in biotech, where he’ll be widely familiar to the people mustering new companies around some emerging technologies.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
-Targets
-Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.